BR9206796A - Forma de dose unitária de subsalicilato de bismuto - Google Patents

Forma de dose unitária de subsalicilato de bismuto

Info

Publication number
BR9206796A
BR9206796A BR9206796A BR9206796A BR9206796A BR 9206796 A BR9206796 A BR 9206796A BR 9206796 A BR9206796 A BR 9206796A BR 9206796 A BR9206796 A BR 9206796A BR 9206796 A BR9206796 A BR 9206796A
Authority
BR
Brazil
Prior art keywords
bismuth subsalicylate
unit dose
dose form
dosage form
unit dosage
Prior art date
Application number
BR9206796A
Other languages
English (en)
Inventor
Mark Matthew Crisanti
Daniel Antonio Murcia
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BR9206796A publication Critical patent/BR9206796A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BR9206796A 1991-11-22 1992-11-16 Forma de dose unitária de subsalicilato de bismuto BR9206796A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79619391A 1991-11-22 1991-11-22
PCT/US1992/009724 WO1993009784A1 (en) 1991-11-22 1992-11-16 Unit dose form of bismuth subsalicylate

Publications (1)

Publication Number Publication Date
BR9206796A true BR9206796A (pt) 1995-05-02

Family

ID=25167573

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9206796A BR9206796A (pt) 1991-11-22 1992-11-16 Forma de dose unitária de subsalicilato de bismuto

Country Status (8)

Country Link
EP (1) EP0681476B1 (pt)
JP (1) JPH07501076A (pt)
AT (1) ATE157250T1 (pt)
BR (1) BR9206796A (pt)
CA (1) CA2122478C (pt)
DE (1) DE69221905T2 (pt)
MX (1) MX9206738A (pt)
WO (1) WO1993009784A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995025521A1 (en) * 1994-03-24 1995-09-28 The Procter & Gamble Company Solid dose forms containing bismuth
US5399356A (en) * 1994-03-24 1995-03-21 The Procter & Gamble Company Process for making solid dose forms containing bismuth
HUP9904073A3 (en) * 1996-11-22 2000-04-28 Procter & Gamble Compositions for the treatment of gastrointestinal disorders containing bismuth and nsaid

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1764933A (en) * 1928-01-12 1930-06-17 Coplans Myer Stable salicylate composition
DE3220765A1 (de) * 1982-06-02 1983-12-08 Alza Corp., 94304 Palo Alto, Calif. Mittel zur kalium-substitutionstherapie
US4588589A (en) * 1983-10-13 1986-05-13 Richardson-Vicks Inc. Antidiarrheal compositions and use thereof

Also Published As

Publication number Publication date
MX9206738A (es) 1993-05-01
CA2122478A1 (en) 1993-05-27
WO1993009784A1 (en) 1993-05-27
JPH07501076A (ja) 1995-02-02
CA2122478C (en) 1998-08-25
EP0681476B1 (en) 1997-08-27
EP0681476A1 (en) 1995-11-15
ATE157250T1 (de) 1997-09-15
DE69221905D1 (de) 1997-10-02
DE69221905T2 (de) 1998-01-29

Similar Documents

Publication Publication Date Title
IE862554L (en) Pharmaceutical compositions
CA2124677A1 (en) Immunopotentiatory agents and physiologically acceptable salts thereof
SE8700499D0 (sv) Novel pharmacologically active compounds
ES2097155T3 (es) Forma de dosificacion efervescente y metodo de administracion.
IL103303A (en) Pharmaceutical compositions containing ibuprofen and codeine for relief of chronic pain
PT85747A (en) Pharmaceutical formulation
FR2514644B1 (pt)
NZ225950A (en) Calcium citrate malate in the molar ratio of 6:2:3; pharmaceutical compositions
ATE181505T1 (de) Phosphozucker enthaltende pharmazeutische zubereitung
FI910088A0 (fi) Oral farmaceutisk komposition.
BR9206796A (pt) Forma de dose unitária de subsalicilato de bismuto
IT8548977A0 (it) Composizioni effervescenti clorate per pastiglie per uso di disinfezione
DE69434210D1 (de) Pharmazeutische antacidzusammensetzung
GB2162748B (en) Medicinal composition for the treatment or prevention of acne by oral administration
DE69231263D1 (de) Calcitonin enthaltende pharmazeutische Zusammensetzungen
DK115789A (da) Farmaceutisk middel til oral indtagelse, isaer til jern- og magnesiumsubstitutionstetapi
DE3473826D1 (en) N,n-diethyl-5-methyl-2h-1-benzothiopyrano-(4,3,2-cd)-indazole-2-ethanamine, compositions comprising the same and uses therefor
DE3260567D1 (en) Analgesic potentiation
IL99512A0 (en) Calcium uptake inhibitors
JPS554397A (en) Novel n11benzoylln22phenyll1*33diaminopropane 22ol*its manufacture and medicine containing it for therapy of acute and chronic gastritis
RO85950B1 (ro) Produs medicamentos cu proprietati analgoantipiretice
RU93036134A (ru) Бишофит как основа для лекарственных препаратов
FR2602679B1 (fr) Nouvelles compositions pharmaceutiques renfermant comme principe actif regulateur du mouvement des ions calcium un fragment du glucagon, et preparation d'un tel fragment
IT1242026B (it) Composizione farmaceutica contenente un complesso ferro-schizokinene per il trattamento dell'anemia ferropenica.
GR3030600T3 (en) Pharmaceutical pentapeptide compositions and methods of use thereof.

Legal Events

Date Code Title Description
EE Request for examination
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
FC Decision: refusal
HIFC Refusal cancelled